The KTH spin-off which will take a billion-dollar market by storm

The biotech company Single Technologies has developed a sort of a cube which can analyse 100 times more DNA at a 100 times lower price than the competitors. The market is worth USD 10 billion - but in a few years it could be ten times as large.

Dagens Industri 10.11.23 English

KTH-spinoffen som ska ta miljardmarknad med storm

Bioteknikbolaget Single Technologies har utvecklat en slags kub som kan analysera 100 gånger mer DNA till ett 100 gånger lägre pris än konkurrenterna. Marknaden är värd 100 miljarder kronor – men om några år kan den vara tio gånger så stor.

Dagens Industri 10.11.23

Sweden's Single Technologies Progresses Towards 3D Sequencing, $10 Human Genome

Johan Strömqvist and Bob Kain were recently interviewed by GenomeWeb. "The firm has come up with a design for a 3D "matrix" to replace the traditional 2D flow cell, which it says can maximize use of reagents, leading to lower costs. Pairing that with its imaging technology, which it claims could become thousands of times faster than confocal imaging," wrote GenomeWeb. "[It's the] first disruptive architecture I've seen since the HiSeq." said Bob Kain

GenomeWeb 11.04.24